Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × ACTH Syndrome, Ectopic × pasireotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Endocrine 1

Conditions

Pituitary Neoplasms 2 Nelson Syndrome 2 Prostatic Neoplasms 1 Pituitary ACTH Hypersecretion 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Meningioma 1 Adrenocortical Hyperfunction 1 ACTH Syndrome, Ectopic 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00958841 2016-07-26

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Novartis

Phase 2 Terminated

118 enrolled 11 charts

EndocrineGastrointestinal

ACTH Syndrome, Ectopic, Nelson Syndrome, Pancreatic Neoplasms, Pituitary Neoplasms, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡